European Union - English - EMA (European Medicines Agency)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - acute coronary syndromemyocardial infarction

United Kingdom - English - myHealthbox

zentiva - atorvastatin - film-coated tablets - 10mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

zentiva - atorvastatin - film-coated tablets - 20mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

zentiva - atorvastatin - film-coated tablets - 80mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

zentiva - atorvastatin - film-coated tablets - 40mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

zentiva - rosuvastatin calcium - film-coated tablets - 5.2mg - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.

United Kingdom - English - myHealthbox

zentiva - rosuvastatin calcium - film-coated tablets - 10.4mg - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.

United Kingdom - English - myHealthbox

zentiva - rosuvastatin calcium - film-coated tablets - 20.8mg - hmg-coa reductase inhibitors - adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

United Kingdom - English - myHealthbox

zentiva - rosuvastatin calcium - film-coated tablets - 41.6mg - hmg-coa reductase inhibitors - treatment of hypercholesterolaemia adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate. prevention of cardiovascular events prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.

United Kingdom - English - myHealthbox

zentiva - vardenafil - film-coated tablets - 5mg - urologicals, drugs used in erectile dysfunction - treatment of erectile dysfunction in adult men. erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.